PTI sources.The committee recommended emergency market approval for Serum Institute of India's Covishield, according to Mint sources.
The SEC met for the third time in a month to look at data provided by Serum Institute and Bharat Biotech for emergency use licence.
Serum Institute of India and Bharat Biotech had applied for emergency use of their coronavirus vaccines last month. Earlier this week, the expert committee sought more data from both the companies to approve the vaccines.Covaxin has been derived from a strain of the novel coronavirus isolated by the National Institute of Virology in Pune.
Bharat Biotech developed an “inactivated" vaccine at its high-containment facility at Genome Valley in Hyderabad. “Once the vaccine is injected.